Success Metrics

Completion Rate
0%(0/1)
Active Trials
1(17%)
Terminated
1(17%)

Phase Distribution

Ph not_applicable
6
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution6 total trials
N/ANon-phased studies
6(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

6

all time

Status Distribution
Active(1)
Terminated(1)
Other(4)

Detailed Status

unknown4
Terminated1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
1
Success Rate
0.0%
Most Advanced
N/A

Trials by Phase

N/A6 (100.0%)

Trials by Status

unknown467%
terminated117%
recruiting117%

Recent Activity

1 active trials
Showing 5 of 6
terminatednot_applicable

Imaging the Effects of rTMS on Chronic Pain

NCT02687360
recruitingnot_applicable

pBFS-guided rTMS Over DMPFC for Treatment-Resistant Depression

NCT06350396
unknownnot_applicable

pBFS Guided rTMS Over DMPFC for Treatment-Resistant Depression

NCT05948839
unknownnot_applicable

pBFS Guided rTMS Therapy for Treatment-resistant Obsessive-Compulsive Disorder

NCT05964049
unknownnot_applicable

pBFS Guided High-dose rTMS Therapy for Treatment-Resistant Obsessive-Compulsive Disorder

NCT05964062
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT02687360Not Applicable

Imaging the Effects of rTMS on Chronic Pain

Terminated
NCT06350396Not Applicable

pBFS-guided rTMS Over DMPFC for Treatment-Resistant Depression

Recruiting
NCT05948839Not Applicable

pBFS Guided rTMS Over DMPFC for Treatment-Resistant Depression

Unknown
NCT05964049Not Applicable

pBFS Guided rTMS Therapy for Treatment-resistant Obsessive-Compulsive Disorder

Unknown
NCT05964062Not Applicable

pBFS Guided High-dose rTMS Therapy for Treatment-Resistant Obsessive-Compulsive Disorder

Unknown
NCT03159351Not Applicable

The Antidepressant Effects of rTMS After Ischemic Stroke

Unknown

All 6 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
6